Skip to content
TrialScanner

NCT02509845

Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects

Phase 2CompletedARMPLead

Registry record

Lead sponsor
Armata Pharmaceuticals, Inc.
Conditions
Dental Caries
Primary completion
Feb 2016Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02509845 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.